Investors in MeiraGTx Holdings (NASDAQ:MGTX) Have Unfortunately Lost 71% Over the Last Five Years
Express News | MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (Rmat) Designation for Aav2-Haqp1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Too Much Debt?
MeiraGTx Holdings Plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
MeiraGTx Holdings Reports Significant Losses Amid Strategic Moves
MeiraGTx Holdings Is Maintained at Outperform by RBC Capital
MeiraGTx Hldgs Analyst Ratings
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $11
Express News | MeiraGTx Holdings PLC : RBC Raises Target Price to $11 From $9
MeiraGTx Holdings | 10-Q: Q3 2024 Earnings Report
MeiraGTx Hldgs Q3 2024 GAAP EPS $(0.55) Misses $(0.53) Estimate, Sales $10.90M Beat $1.63M Estimate
MeiraGTx Holdings | 8-K: MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
Earnings Flash (MGTX) MEIRAGTX Posts Q3 Revenue $10.9M
MeiraGTx Holdings: Runway to Fund Operating Expenses, Capital-Spending Needs Into 2Q 2026 >MGTX
Press Release: MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
MeiraGTx Holdings 3Q Loss/Shr 55c >MGTX
MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good
Express News | MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (Esgct) 2024 Annual Congress